Novartis AG (ADR)

General ticker "NVS" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $203.6B

Novartis AG (ADR) follows the US Stock Market performance with the rate: 25.9%.

Estimated limits based on current volatility of 0.7%: low 96.67$, high 98.10$

Factors to consider:

  • Company pays dividends: last record date 2024-03-08, amount 3.78$ (Y15.36%)
  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [80.99$, 117.36$]
  • 2024-12-30 to 2025-12-30 estimated range: [83.78$, 122.41$]

Financial Metrics affecting the NVS estimates:

  • Positive: Non-GAAP EPS, $ of 6.81 > 2.29
  • Negative: Industry earnings per price (median), % of -15.01 <= 1.31
  • Positive: Interest expense per share, $ of 0.41 <= 0.74
  • Positive: Inventory ratio change, % of -0.90 <= 0
  • Positive: Return on assets ratio (scaled to [-100,100]) of 7.90 > 7.10

Similar symbols

Short-term NVS quotes

Long-term NVS plot with estimates

Financial data

YTD 2022-12-31 2023-12-31
Operating Revenue $51,828.00MM $46,660.00MM
Operating Expenses $42,631.00MM $36,891.00MM
Operating Income $9,197.00MM $9,769.00MM
Non-Operating Income $-826.00MM $-646.00MM
Interest Expense $837.00MM $855.00MM
R&D Expense $9,996.00MM $11,371.00MM
Income(Loss) $8,371.00MM $9,123.00MM
Taxes $1,416.00MM $551.00MM
Profit(Loss) $6,955.00MM $8,572.00MM
Stockholders Equity $59,342.00MM $46,667.00MM
Inventory $7,175.00MM $5,913.00MM
Assets $117,453.00MM $99,945.00MM
Operating Cash Flow $14,236.00MM $14,458.00MM
Capital expenditure $2,671.00MM $2,753.00MM
Investing Cash Flow $1,468.00MM $5,596.00MM
Financing Cash Flow $-20,562.00MM $-14,278.00MM
Earnings Per Share* $3.19 $7.15

* EPS are Split Adjusted, recent splits may be reflected with a delay.